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ABSTRACT 
Diabetic Retinopathy (DR) is the most prevalent health problem, which is influenced by environmental and genetic 
factors with an increasing prevalence. The current systematic review is focused on mtDNA modification, including 
polymorphism and mutation/deletion, with a direct effect on DR.This systematic search was initially done through 
PubMed, Cochrane, EMBASE, SCOPUS, and Web of Science without a restriction on the years of publication. The terms 
searched included ‘‘mtDNA’’, ‘‘mitochondrial DNA’’, ‘‘diabetes’’, ‘‘diabetic’’, ‘‘retina’’, and ‘‘diabetic retinopathy’’. 
Animal, cohort, cross-sectional, and in vitro studies, as well as case series, case reports, review articles, and Letters to 
Editor were excluded from this research.From 1528 resulting searched articles, only 12papers were finally chosen as the 
case-control studies considering mtDNA gene and DR. Actually, of these 12 articles, 8 studies were concerned with 
mtDNA polymorphisms (UCP1, UCP2, ROMO-1, and Mn-SOD) and 4 articles were related to mtDNA mutation (A3243G 
mutation in tRNALeu(UUR) gene and mtDNA deletion (ΔmtDNA 4977)).Some conflicting results were found between the 
selected genetic modifications of mtDNA, such as Mn-SOD, UCP1, ΔmtDNA 4977, tRNALeu (UUR), and ROMO-1.Finally, 
A3243G mutation in the tRNALeu (UUR) gene and rs660339 and V16A polymorphisms of UCP2 and Mn-SOD genes were 
respectively considered as the most important factors in the pathogenesis of DR. 
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INTRODUCTION
As a major public health problem, diabetes became an 
epidemic disease in the 21
st
 century. The functions of 
different organs are influenced by the disease, which 
either reduces life quality or leads to death in some cases 
[1, 2]. An increased circulation of blood glucose through 
blood vessels is induced by this lifelong disease, which 
results in varied micro- and macro-vascular 
complications. Though preventable in the developed 
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countries, Diabetic Retinopathy (DR) as one of the most 
severe types of these complications mainly leads to 
blindness in the vision-disabled elderly [2-5]. An 
increasing prevalence of diabetes has been reported by 
the International Diabetes Federation (IDF). 
Approximately, one-third of diabetic people (93 out of 
246 million people) estimated for DR symptoms, whom 
17 and 28 million people of them have developed 
Proliferative Diabetic Retinopathy (PDR) and vision-
threatening conditions like Diabetic Macular Edema 
(DME), respectively [1]. DR develops at a slow rate of 
progression in such a way that involved patients show no 
symptoms at the beginning and when they began to 
experience a deteriorating eye sight, they have been 
already involved in an advanced level of retinopathy, 
which can then lead to the loss of vision if not controlled 
[3]. Early detection of the disease and its treatment are 
important for improving the diabetic patients’ qualities 
of life [6]. In addition to hyperglycemia, which is the 
principal cause of DR progression, hypertension and 
dyslipidemia are some other risk factors associated with 
the disease [4, 7]. The exact mechanism of the 
pathogenesis of DR is not clear. A cascade of biochemical 
and physiological changes that finally cause micro-
vascular impairment and retinal dysfunction leads to 
various clinical conditions[4]. Several biochemical 
pathways are involved in the increasing amounts of 
sorbitol and Advanced Glycation End-products (AGEs), 
oxidative stress, protein kinase C activation, 
inflammation, and angiogenesis induced by Vascular 
Endothelial Growth Factor (VEGF), which modulates the 
pathogenesis of retinopathy [8]). Under the influences of 
many molecular, biochemical, and functional 
abnormalities, the retinal mitochondria become 
dysfunctional in DR [3, 9], while their copy numbers are 
reduced and DNAs (mtDNAs) are damaged [10]. 
Mitochondrial DNA (mtDNA) is a double-stranded circular 
molecule with 16,569 base pairs length, which is packed 
as nucleoid-like structures unlike nuclear DNA with 
introns and nucleosomes, lacks protective histones, and 
has a non-coding region and Displacement loop (D-loop) 
that contains essential transcription and replication 
elements. Hence, it is 10-20 times more susceptible to 
oxidative impairment than nuclear DNA [10-13]. The 
damage is more extensive at the D-loop than at any 
other regions of the mtDNA[14]. Decreased copy 
numbers of mtDNA and transcriptions of mtDNA-
encoded genes, which play a vital role in the functioning 
of the electron-transport system occur [6]. Superoxide 
levels are elevated and the enzymeMnSOD is responsible 
[15-17]. Also, initializations of the apoptotic machinery 
and capillary cell apoptosis proceed the development of 
retinal histopathology associated with DR [9, 18,19]. 
Besides the metabolic and physiologic factors, the 
pathogenesis of DR is affected by genetic factors. The risk 
of severe DR in the patient’s siblings is almost three 
times higher, while diabetic patients with the same risk 
factors are involved in varying severities of retinopathy 
[20, 21]. Some cohort studies indicated the fact that 
mtDNA variations are associated with the severity but 
not presence of DR [22, 23]. Some data reveal that the 
effects of mtDNA variations like Single Nucleotide 
Polymorphism (SNP) and genetic mutations, as well as 
ischemia or neovascularization are related to the 
features of PDR. There are a wide range of studies, in 
which a correlation between mtDNA gene modification 
and DR has been found. Most of them are review studies, 
but none of them is a systematic review [24-26]. Thus, 
the current research was conducted to represent a 
collection of all analytical observational studies related to 
the mtDNA mutations and SNPs in a systematic review. In 
fact, the aim of our study was to review the importance 
of mtDNA variations and the risk of DR. 
MATHRIALS AND METHODS 
Data Sources and Searches 
This study was developed according to Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines. After receiving Prospero 
code (CRD42017058832), a computerized search was 
done in the relevant literature to retrieve the evidence 
on the topic by using the databases of Cochrane, 
PubMed, EMBASE, SCOPUS, and Web of Science, as well 
as keywords of ‘‘mtDNA’’, ‘‘mitochondrial DNA’’, 
‘‘diabetes’’, ‘‘diabetic’’, ‘‘retina’’, and ‘‘diabetic 
retinopathy’’ without any limitations on the years of 
publication. To perform a comprehensive search, 
different combinations of the mentioned terms were 
utilized. The titles and abstracts of all the search results 
were examined to eliminate the duplications and 
multiple publications from the same research, while the 
most relevant data were employed for the investigation. 
Also, to find any additional publications related to the 
topic, the lists of references included in the papers were 
searched manually. 
Selection of the Studies 
For assessing the association between mtDNA and DR, 
we included all the observational studies performed as 
case-control and cross-sectional studies only on humans. 
Any additional abstracts or unpublished studies like 
those carried out in vitro or on animals, theses or 
dissertations, short communications, reports, Letters to 
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Editor, patents, and reviews or mini-reviews were 
excluded from the current systematic review. Also, the 
titles and abstracts of the publications were screened to 
exclude any irrelevant findings. Moreover, 2 reviewers 
(FKH and NS) evaluated the eligible articles based on the 
inclusion and exclusion criteria by independently 
reviewing their titles and abstracts. Then, to find the 
relevant publications to the topic, the same reviewers 
fully assessed the texts. Any cases of conflicts were 
supervised by a third reviewer (MMA) for selecting and 
screening the studies. 
Data Extraction 
The data for each study were extracted by using a 
standardized data extraction form, which was designed 
to include the following information in an Excel sheet: 
Patient’s characteristics (sample size, age, and sex), study 
design, method of analysis, author(s), year, 
polymorphism and mutation, city, ID number, and 
significant association. 
RESULTS 
Most researches were in-vitro studies and review 
articles. 144papers were investigated for content and 
only 12 relevant articles were finally selected as an 
additional step. Of these 12 articles (3256 vs. 2910), 8 
and 4 studies were concerned with mtDNA 
polymorphisms and mtDNA mutations and deletions, 
respectively (Fig 1). 
 
Figure 1: A Flow Diagram Presenting the Results of the Literature Search and Selection Processes of the Studies 
 
Totally, different polymorphisms and mutations of the 
following genetic variants and mutations were found in 
the selected studies (Table1): 
Thermogenin (uncoupling protein 1 or UCP1) is an 
uncoupling protein found in the mitochondria of Brown 
Adipose Tissue (BAT). Mitochondrial uncoupling proteins 
(UCP) are members of the larger family of Mitochondrial 
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Anion Carrier Proteins (MACP). UCPs separate oxidative 
phosphorylation from ATP synthesis with energy 
dissipated as heat. UCPs smooth the progress of anion 
transfer from the inner to the outer mitochondrial 
membrane and proton insertion from the outer to the 
inner mitochondrial membrane. Their role is to produce 
heat through non-shivering thermogenesis. 
 Mitochondrial uncoupling protein 2 (UCP2) is a protein 
that is encoded by UCP2 gene in humans. It has a role in 
H+/OH- transfer. This gene is expressed in many tissues 
with a maximum expression in the skeletal muscle. 
Although it has been originally thought to play a role in 
no-shivering thermogenesis, obesity, diabetes, and 
atherosclerosis, it now appears that the main function of 
UCP2 is to control mitochondria-derived Reactive Oxygen 
Species (ROS). 
Manganese superoxide dismutase (Mn-SOD) in the 
mitochondrial antioxidant defense system whichis 
completely activated in the mitochondria to detoxify the 
oxygen free radicals generated by mitochondrial 
respiration. Thus, oxidative stress leads to the up-
regulation of Mn-SOD gene whose activity can be further 
enhanced by the Mitochondrial Protein Influx (MPI). 
 Reactive oxygen species modulator 1 (Romo1) is a 
mitochondrial membrane protein responsible for 
increasing ROS levels in cells. The protein also has 
antimicrobial activities against a variety of bacteria by 
inducing bacterial membrane breakage. 
 The common mitochondrial DNA4977-bp deletion 
(mtDNA 4977) often happens in the tissues of high 
oxygen demands and low mitotic activities, including the 
brain, heart, and skeletal muscle. 
MT-TL1 gene encoding tRNAleucine 1, tRNA
Leu(UUA/UUG)
, is 
designated as mitochondrial tRNA
Leu (UUR)
gene. This 
molecule inserts theleucine (Leu) into proper locations 
during protein growth after attaching to it. It is present in 
cellular structures like mitochondrial structure and 
converts food energy into a usable form of energy for 
cells. It further participates in the mitochondrial protein 
assembly that contributes to the oxidative 
phosphorylation process, through which oxygen, simple 
sugars, and fatty acids are mixed to make adenosine 
triphosphate (ATP) as the main source of energy for cells. 
 
Table1: Characteristics of the Selected Studies on mtDNA and DR 
First Author Title Countr
y 
Year Case
s/Co
ntrol
s 
Mean 
age of 
Case 
Mean 
age of 
Contro
ls 
mtDNA Modification Methods 
Alessandro 
Achilli[25] 
Mitochondrial DNA Backgrounds 
Might Modulate Diabetes 
Complications Rather than T2DM as a 
Whole 
Italy 2011 466/
438 
65.84
68.19 
59.96
69.97 
57 different 
mtDNAhaplogroups 
and sub-haplogroups 
Sequencing of 
entire mtDNA 
genomes 
Daisy 
Crispim[26] 
Polymorphisms of the UCP2 gene are 
associated with proliferative diabetic 
retinopathy in patients with diabetes 
mellitus 
Brazil 2010 325/
369 
50.2 46.8 Polymorphism 
(866G/A, Ala55Val and 
Ins/Del 
polymorphisms in the 
UCP2 gene) 
RFLP Real time 
PCR 
Masataka 
Fukuda [27] 
Mitochondrial DNA Mutations Are 
Associated with Both Decreased 
Insulin Secretion and Advanced 
Microvascular Complications in 
Japanese Diabetic Subjects 
Japan 1999 537/
612 
60.3 ± 
0.6 
49.5 ± 
0.7 
mtDNA mutation 
(eight kinds of Mt-
DNA point mutations 
and all of which were 
single mutations were 
found in 74 subjects) 
PCR-RFLP 
(Digestion) 
S.F.Haghighi[
28] 
Polymorphic Variant of MnSODA16V 
and Risk of Diabetic Retinopathy 
Iran 2014 140/
140 
52.5 ± 
22.5 
52.5 ± 
22.5 
Polymorphism 
(MnSODA16VC47T) 
PCR-RFLP 
Seong Jin Lee 
[29] 
Association of manganese superoxide 
dismutase gene polymorphism 
(V16A) with diabetic macular edema 
in Korean type 2 diabetic patients 
Korea 2006 304/
192 
53.4 ± 
13.3 
52.1 ± 
13.2 
Polymorphism (V16A 
polymorphism of the 
Mn-SOD and 
polymorphic region of 
the ACE gene) 
PCR-RFLP 
MojcaGloboˇ
cnikPetroviˇ 
Manganese superoxide dismutase 
gene polymorphism (V16A) is 
Sloveni
a 
2008 283/
143 
66.0 ± 
9.5 
66.9 ± 
11.5 
Polymorphism (V16A 
polymorphism of the 
PCR-RFLP 
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[30] associated with diabetic retinopathy 
in Slovene (Caucasians) type 2 
diabetes patients 
Mn-SOD gene) 
MojcaGloboc
nikPetrovic[3
1] 
The rs6060566 of the reactive oxygen 
speciesmodulator 1 (Romo-1) gene 
affects Romo-1expression and the 
development of diabeticretinopathy 
in Caucasians with type 2 diabetes 
Sloveni
a 
2015 278/
528 
64.9 ± 
8.0 
63.8 ± 
9.0 
Polymorphism 
(rs6060566 of the 
ROMO-1 gene) 
fluorescence-
based 
competitive 
allelespecificPCR 
(KASPar) assay 
YinchenShen[
32] 
Investigation of Variants in UCP2 in 
Chinese Type 2 Diabetes and Diabetic 
Retinopathy 
China 2014 324/
155 
58.15 
±12.52 
60.15 
±10.90 
Polymorphism 
(rs660339 in the exon 
4 and rs659366 in 
promoter region of 
UCP2 gene) 
sequencing 
VanitaVanita
[33] 
Association of RAGE (p.Gly82Ser) and 
MnSOD (p.Val16Ala) Polymorphisms 
with Diabetic Retinopathy in T2DM 
patients from North India 
India 2014 446/
312 
55.92 ± 
8.90 
55.84 ± 
12.2 
Polymorphism 
(Gly82Ser (RAGE) and 
Val16Ala (MnSOD)) 
sequencing 
Yue Zhang 
[34] 
The gene polymorphisms of UCP1 but 
not PPAR c and TCF7L2 are associated 
with diabetic retinopathy in Chinese 
type 2 diabetes mellitus cases 
China 2015 448/
344 
62.35 ± 
11.92 
60.16 ± 
11.67 
polymorphisms 
(rs1800592 in the 
UCP1 gene, 
rs1801282, rs3856806 
and rs1249719 in the 
PPARc gene and 
rs11196205 in the 
TCF7L2 gene) 
PCR-LDR 
(polymerasechain 
reaction-ligase 
detection 
reactions) 
D.J. Holmes-
Walker [35] 
Does Mitochondrial Genome 
Mutation in Subjects with Maternally 
Inherited Diabetes and Deafness 
Decrease Severity of Diabetic 
Retinopathy? 
Austral
ia 
1998 18/1
1 
42.1 6 
13.8 
42.36 
14.9 
The 3243 mutation 
3243 A-G tRNALEU (UUR) 
point mutation of 
mitochondrial DNA 
- 
Susumu 
Suzuki [14] 
Oxidative damage to mitochondrial 
DNA and its relationship to diabetic 
complications 
Japan 1999  22/7 - mtDNA deletion of 
4977 bp 
(DmtDNA4977) 
Quantification of 
mtDNA4977 with 
ompetiti6e PCR 
 
DISCUSSION
DR is a common life-affecting micro-vascular 
complication of diabetes and the main cause of new 
cases of blindness troubling adult patients with diabetes 
mellitus [36]. Diabetes has such a complex and wide-
ranging pathophysiology that necessitates numerous 
studies to be focused on finding its genetic modifications 
[37-43]. It has been shown that increasing oxidative 
stress in the retinas of diabetic patients leads to the 
escalation of oxidative modified DNA [44]. Augmented 
oxidative stress through hyperglycemia possibly 
contributes to the pathogenesis of diabetic complications 
with aDNA marker of 8-hydroxydeoxyguanosine (8-
OHdG), which is coupled with mtDNA deletions [11]. 
mtDNA 4977-bp (ΔmtDNA4977) deletion and 8-OHdG 
content in the muscle DNA of Non-Insulin-Dependent 
Diabetes Mellitus (NIDDM) patients have been found to 
be actually much higher than those of the control 
subjects [11]. Moreover, ΔmtDNA4977 and 8-OHdG 
content are interrelated with the duration and severity of 
diabetic nephropathy and retinopathy[11]. The functions 
of antioxidants in the management of diabetes and its 
complications have been studied several times [45, 46]. 
The rs6060566 polymorphism of Romo-1 gene is linked 
with DR development [33]. Besides, the rs6060566 
polymorphism can be mediated by the expression of 
Romo-1 gene in the retina [33]. There is some evidence 
that the genetic variation of mtDNA contributes to the 
pathogenesis of DR. mtDNA modification includes the 
genetic variants (polymorphisms) of a common 
population, by which human population is separated into 
somatic mutations of mtDNA[47] and mitochondrial copy 
number changes as a result of Displacement-loop (D-
loop) [48, 49]. Diabetes complications developed by 
important mtDNA variations are usually classified into 
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micro-vascular complications, including diabetic 
nephropathy, neuropathy, and retinopathy and macro-
vascular complications, such as cardiovascular diseases, 
cerebrovascular accidents, and peripheral vascular 
diseases [50, 51]. Interestingly, SNP rs1800592 of UCP1, 
but not peroxisome proliferators-activated receptor-
gamma (PPARγ) and Transcription factor7-like2 (TCF7L2) 
has been found to be coupled with DR in a sample of 
Chinese patients [52]. The two important mtDNA genes 
in the pathogenesis of DR are uncoupling proteins 1 and 
2 (UCP1 and UCP2) with the main role of controlling ROS. 
UCP2 separates the substrate oxidation from ATP 
synthesis and thus reduces ATP production by the 
mitochondrial respiratory chain [53-55]. It has been 
checked whether rs659366, rs660339, and 45-bp 
Insertion/Deletion (Ins/Del) polymorphisms in the UCP2 
gene may be associated with PDR [28, 34]. The rs660339 
has been found as an important risk factor associated 
with DR in both type 1 and 2diabetes groups [28]. 
Moreover, the protective effect of magnesium on the 
renal functions of diabetic rats has been shown [55-57]. 
In fact, Mn-SOD is a mitochondrial antioxidant enzyme 
located in the cellular defense system against the agents 
that induce oxidative stress [58, 59]. Mn-SOD A16V 
(C47T) polymorphism has been shown to be associated 
with the risk of DR[30]. Evaluation of the V16A 
polymorphism of the Mn-SOD gene during diabetes 
development has shown an association between its VV 
genotype and DR in Caucasians with type 2 diabetes [32]. 
Hence, the mentioned polymorphism can provide a 
genetic marker of DR in Caucasians [32]. These conflicting 
results revealed that the V16A polymorphism of the Mn-
SOD gene is not connected to the development of 
diabetes and progression of DR, but is associated with 
DME [31]. These findings were found to be in agreement 
with the results of another case-control study that 
evaluated the association of the Receptor for Advanced 
Glycation End-products (RAGE) (p.Gly82Ser) and Mn-SOD 
(p.Val16Ala) polymorphisms with DR in diabetic patients. 
The findings indicated a statistically significant 
association only between RAGE Gly82Ser polymorphism 
and DR [35]. The most frequent mtDNA mutation for 
diabetes is the A3243G mutation in the tRNA
Leu (UUR) 
gene 
[60, 61]. The sequencing results of an mtDNA fragment 
surrounding the tRNA
Leu (UUR) 
site suggested that mtDNA 
mutations in Japanese diabetic subjects are completely 
correlated with diabetes and advanced diabetic micro 
vascular complications [29]. Additional studies have 
demonstrated that abnormal glucose tolerance raises the 
clinical expression of pigmentary retinopathy in patients 
with a mitochondrial genome mutation [62]. Due to the 
heterogeneity of the selected mtDNA variations in this 
paper, a meta-analysis was not followed in our 
qualitative systematic review. By way of illustration, the 
genetic variations were completely different both in the 
candidate genes and selected polymorphisms with varied 
impacts on the gene expression profile. 
CONCLUSIONS 
Taking everything into consideration, the importance of 
mitochondria in DR was found to be hidden in the 
variations in its genes like A3243G mutation in the 
tRNA
Leu (UUR) 
gene, and ΔmtDNA4977, Mn-SOD A16V 
(C47T), UCP1, UCP2, and ROMO-1 polymorphisms. 
 
ACKNOWLEDGEMENTS 
This research was supported by Endocrinology and 
Metabolism Research Center. 
 
DISCLOSURE 
No funding or sponsorship was received for this study. All 
named authors meet the International Committee of 
Medical Journal Editors (ICMJE) criteria for authorship for 
this manuscript, take responsibility for the integrity of 
the work as a whole, and have given final approval for 
the version to be published.  
 
REFERENCES
1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF 
diabetes atlas: global estimates of the prevalence of 
diabetes for 2011 and 2030. Diabetes Res Clin Pract. 
2011;94(3):311-21. DOI: 
10.1016/j.diabres.2011.10.029PMID: 22079683 
2. Kowluru RA, Kowluru A, Mishra M, Kumar B. 
Oxidative stress and epigenetic modifications in the 
pathogenesis of diabetic retinopathy. Prog Retin Eye 
Res. 2015;48:40-61. DOI: 
10.1016/j.preteyeres.2015.05.001PMID: 25975734 
3. Frank RN. Diabetic retinopathy. N Engl J Med. 
2004;350(1):48-58. DOI: 
10.1056/NEJMra021678PMID: 14702427 
4. Cheung N, Mitchell P, Wong TY. Diabetic Retinopath. 
The Lancet. 2010;376(9735):124-36. DOI: 
10.1016/s0140-6736(09)62124-3 
 
 
Med Hypothesis DiscovInnovOphthalmol. 2017; 6(2)  
 
36 
 
MITOCHONDRIAL DNA IN THE DEVELOPMENT OF DIABETIC RETINOPATHY 
5. Simo-Servat O, Simo R, Hernandez C. Circulating 
Biomarkers of Diabetic Retinopathy: An Overview 
Based on Physiopathology. J Diabetes Res. 
2016;2016:5263798. DOI: 
10.1155/2016/5263798PMID: 27376090 
6. Mishra M, Lillvis J, Seyoum B, Kowluru RA. Peripheral 
Blood Mitochondrial DNA Damage as a Potential 
Noninvasive Biomarker of Diabetic Retinopathy. 
Invest Ophthalmol Vis Sci. 2016;57(10):4035-44. DOI: 
10.1167/iovs.16-19073PMID: 27494345 
7. Kowluru RA, Mishra M. Contribution of epigenetics in 
diabetic retinopathy. Sci China Life Sci. 
2015;58(6):556-63. DOI: 10.1007/s11427-015-4853-
0PMID: 26025281 
8. Fong DS, Aiello LP, Ferris FL, 3rd, Klein R. Diabetic 
retinopathy. Diabetes Care. 2004;27(10):2540-53. 
PMID: 15451934 
9. Madsen-Bouterse SA, Mohammad G, Kanwar M, 
Kowluru RA. Role of mitochondrial DNA damage in 
the development of diabetic retinopathy, and the 
metabolic memory phenomenon associated with its 
progression. Antioxid Redox Signal. 2010;13(6):797-
805. DOI: 10.1089/ars.2009.2932PMID: 20088705 
10. Tewari S, Santos JM, Kowluru RA. Damaged 
mitochondrial DNA replication system and the 
development of diabetic retinopathy. Antioxid Redox 
Signal. 2012;17(3):492-504. DOI: 
10.1089/ars.2011.4333PMID: 22229649 
11. Suzuki S, Hinokio Y, Komatu K, Ohtomo M, Onoda M, 
Hirai S, et al. Oxidative damage to mitochondrial DNA 
and its relationship to diabetic complications. 
Diabetes Res Clin Pract. 1999;45(2-3):161-8. PMID: 
10588369 
12. Richter C. Oxidative damage to mitochondrial DNA 
and its relationship to ageing. Int J Biochem Cell Biol. 
1995;27(7):647-53. PMID: 7648420 
13. Liu P, Demple B. DNA repair in mammalian 
mitochondria: Much more than we thought? Environ 
Mol Mutagen. 2010;51(5):417-26. DOI: 
10.1002/em.20576PMID: 20544882 
14. Mishra M, Kowluru RA. Epigenetic Modification of 
Mitochondrial DNA in the Development of Diabetic 
Retinopathy. Invest Ophthalmol Vis Sci. 
2015;56(9):5133-42. DOI: 10.1167/iovs.15-
16937PMID: 26241401 
15. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial 
superoxide dismutase in the development of diabetic 
retinopathy. Invest Ophthalmol Vis Sci. 
2006;47(4):1594-9. DOI: 10.1167/iovs.05-1276PMID: 
16565397 
16. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative 
damage in the retinal mitochondria of diabetic mice: 
possible protection by superoxide dismutase. Invest 
Ophthalmol Vis Sci. 2007;48(8):3805-11. DOI: 
10.1167/iovs.06-1280PMID: 17652755 
17. Du Y, Miller CM, Kern TS. Hyperglycemia increases 
mitochondrial superoxide in retina and retinal cells. 
Free Radic Biol Med. 2003;35(11):1491-9. PMID: 
14642397 
18. Kowluru RA. Mitochondria damage in the 
pathogenesis of diabetic retinopathy and in the 
metabolic memory associated with its continued 
progression. Curr Med Chem. 2013;20(26):3226-33. 
PMID: 23745551 
19. Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, 
Romeo G, et al. Response of capillary cell death to 
aminoguanidine predicts the development of 
retinopathy: comparison of diabetes and 
galactosemia. Invest Ophthalmol Vis Sci. 
2000;41(12):3972-8. PMID: 11053301 
20. Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, 
Davis MD, et al. Heritability of the severity of diabetic 
retinopathy: the FIND-Eye study. Invest Ophthalmol 
Vis Sci. 2008;49(9):3839-45. DOI: 10.1167/iovs.07-
1633PMID: 18765632 
21. Looker HC, Nelson RG, Chew E, Klein R, Klein BE, 
Knowler WC, et al. Genome-wide linkage analyses to 
identify Loci for diabetic retinopathy. Diabetes. 
2007;56(4):1160-6. DOI: 10.2337/db06-1299PMID: 
17395753 
22. Bregman JA, Herren DJ, Estopinal CB, Chocron IM, 
Harlow PA, Warden C, et al. Mitochondrial 
Haplogroups Affect Severity But Not Prevalence of 
Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 
2017;58(2):1346-51. DOI: 10.1167/iovs.16-
20616PMID: 28245487 
23. Crispim D, Fagundes NJ, Canani LH, Gross JL, Tschiedel 
B, Roisenberg I. Role of the mitochondrial 
m.16189T>C variant in type 2 diabetes mellitus in 
southern Brazil. Diabetes Res Clin Pract. 
2006;74(2):204-6. DOI: 
10.1016/j.diabres.2006.05.007PMID: 16784794 
24. Simo-Servat O, Hernandez C, Simo R. Genetics in 
diabetic retinopathy: current concepts and new 
insights. Curr Genomics. 2013;14(5):289-99. DOI: 
10.2174/13892029113149990008PMID: 24403848 
25. Cho H, Sobrin L. Genetics of diabetic retinopathy. Curr 
Diab Rep. 2014;14(8):515. DOI: 10.1007/s11892-014-
0515-zPMID: 24952107 
 
 
Med Hypothesis DiscovInnovOphthalmol. 2017; 6(2)  
 
37 
 
MITOCHONDRIAL DNA IN THE DEVELOPMENT OF DIABETIC RETINOPATHY 
26. Pillai G, Varky R. Genetics in diabetic retinopathy - A 
brief review. Kerala J Ophthalmol. 2016;28(1):14. DOI: 
10.4103/0976-6677.193880 
27. Brondani LA, de Souza BM, Duarte GC, Kliemann LM, 
Esteves JF, Marcon AS, et al. The UCP1 -3826A/G 
polymorphism is associated with diabetic retinopathy 
and increased UCP1 and MnSOD2 gene expression in 
human retina. Invest Ophthalmol Vis Sci. 
2012;53(12):7449-57. DOI: 10.1167/iovs.12-
10660PMID: 23033381 
28. Crispim D, Fagundes NJ, dos Santos KG, Rheinheimer 
J, Boucas AP, de Souza BM, et al. Polymorphisms of 
the UCP2 gene are associated with proliferative 
diabetic retinopathy in patients with diabetes 
mellitus. Clin Endocrinol (Oxf). 2010;72(5):612-9. DOI: 
10.1111/j.1365-2265.2009.03684.xPMID: 19681913 
29. Fukuda M, Nakano S, Imaizumi N, Kitazawa M, 
Nishizawa M, Kigoshi T, et al. Mitochondrial DNA 
mutations are associated with both decreased insulin 
secretion and advanced microvascular complications 
in Japanese diabetic subjects. J Diabetes 
Complications. 1999;13(5-6):277-83. PMID: 10765002 
30. Haghighi SF, Salehi Z, Sabouri MR, Abbasi N. 
[Polymorphic variant of MnSOD A16V and risk of 
diabetic retinopathy]. Mol Biol (Mosk). 
2015;49(1):114-8. PMID: 25916115 
31. Lee SJ, Choi MG. Association of manganese 
superoxide dismutase gene polymorphism (V16A) 
with diabetic macular edema in Korean type 2 
diabetic patients. Metabolism. 2006;55(12):1681-8. 
DOI: 10.1016/j.metabol.2006.08.011PMID: 17142144 
32. Petrovic MG, Cilensek I, Petrovic D. Manganese 
superoxide dismutase gene polymorphism (V16A) is 
associated with diabetic retinopathy in Slovene 
(Caucasians) type 2 diabetes patients. Dis Markers. 
2008;24(1):59-64. PMID: 18057537 
33. Petrovic MG, Kruzliak P, Petrovic D. The rs6060566 of 
the reactive oxygen species modulator 1 (Romo-1) 
gene affects Romo-1 expression and the development 
of diabetic retinopathy in Caucasians with type 2 
diabetes. Acta Ophthalmol. 2015;93(8):e654-7. DOI: 
10.1111/aos.12723PMID: 25824963 
34. Shen Y, Wen Z, Wang N, Zheng Z, Liu K, Xia X, et al. 
Investigation of variants in UCP2 in Chinese type 2 
diabetes and diabetic retinopathy. PLoS One. 
2014;9(11):e112670. DOI: 
10.1371/journal.pone.0112670PMID: 25396419 
35. Vanita V. Association of RAGE (p.Gly82Ser) and 
MnSOD (p.Val16Ala) polymorphisms with diabetic 
retinopathy in T2DM patients from north India. 
Diabetes Res Clin Pract. 2014;104(1):155-62. DOI: 
10.1016/j.diabres.2013.12.059PMID: 24529564 
36. Fong DS, Aiello L, Gardner TW, King GL, Blankenship 
G, Cavallerano JD, et al. Retinopathy in diabetes. 
Diabetes Care. 2004;27 Suppl 1:S84-7. PMID: 
14693935 
37. Dupuis J, Langenberg C, Prokopenko I, Saxena R, 
Soranzo N, Jackson AU, et al. New genetic loci 
implicated in fasting glucose homeostasis and their 
impact on type 2 diabetes risk. Nat Genet. 
2010;42(2):105-16. DOI: 10.1038/ng.520PMID: 
20081858 
38. Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, 
Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic 
variants and risk of type 2 diabetes: a mendelian 
randomisation study. Lancet Diabetes Endocrinol. 
2017;5(2):97-105. DOI: 10.1016/S2213-
8587(16)30396-5PMID: 27908689 
39. Franzago M, Fraticelli F, Nicolucci A, Celentano C, 
Liberati M, Stuppia L, et al. Molecular Analysis of a 
Genetic Variants Panel Related to Nutrients and 
Metabolism: Association with Susceptibility to 
Gestational Diabetes and Cardiometabolic Risk in 
Affected Women. J Diabetes Res. 
2017;2017:4612623. DOI: 
10.1155/2017/4612623PMID: 28133617 
40. Bazzaz JT, Amoli MM, Pravica V, Chandrasecaran R, 
Boulton AJ, Larijani B, et al. eNOS gene polymorphism 
association with retinopathy in type 1 diabetes. 
Ophthalmic Genet. 2010;31(3):103-7. DOI: 
10.3109/13816810.2010.482553PMID: 20565248 
41. Mehrab-Mohseni M, Tabatabaei-Malazy O, Hasani-
Ranjbar S, Amiri P, Kouroshnia A, Bazzaz JT, et al. 
Endothelial nitric oxide synthase VNTR (intron 4 a/b) 
polymorphism association with type 2 diabetes and 
its chronic complications. Diabetes Res Clin Pract. 
2011;91(3):348-52. DOI: 
10.1016/j.diabres.2010.12.030PMID: 21256614 
42. Tavakkoly-Bazzaz J, Amoli MM, Pravica V, 
Chandrasecaran R, Boulton AJ, Larijani B, et al. VEGF 
gene polymorphism association with diabetic 
neuropathy. Mol Biol Rep. 2010;37(7):3625-30. DOI: 
10.1007/s11033-010-0013-6PMID: 20352346 
43. Amoli MM, Amiri P, Alborzi A, Larijani B, Saba S, 
Tavakkoly-Bazzaz J. VEGF gene mRNA expression in 
patients with coronary artery disease. Mol Biol Rep. 
2012;39(9):8595-9. DOI: 10.1007/s11033-012-1713-
xPMID: 22711306 
44. Kowluru RA. Diabetic retinopathy: mitochondrial 
dysfunction and retinal capillary cell death. Antioxid 
 
 
Med Hypothesis DiscovInnovOphthalmol. 2017; 6(2)  
 
38 
 
MITOCHONDRIAL DNA IN THE DEVELOPMENT OF DIABETIC RETINOPATHY 
Redox Signal. 2005;7(11-12):1581-87. DOI: 
10.1089/ars.2005.7.1581PMID: 16356121 
45. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review 
on the role of antioxidants in the management of 
diabetes and its complications. Biomed 
Pharmacother. 2005;59(7):365-73. DOI: 
10.1016/j.biopha.2005.07.002PMID: 16081237 
46. Larijani S. Editorial Positions. Iranian J Endocrinol 
Metab. 1999;1(2):125-33.  
47. Schon EA, DiMauro S, Hirano M. Human 
mitochondrial DNA: roles of inherited and somatic 
mutations. Nat Rev Genet. 2012;13(12):878-90. DOI: 
10.1038/nrg3275PMID: 23154810 
48. Mishra M, Kowluru RA. Retinal mitochondrial DNA 
mismatch repair in the development of diabetic 
retinopathy, and its continued progression after 
termination of hyperglycemia. Invest Ophthalmol Vis 
Sci. 2014;55(10):6960-7. DOI: 10.1167/iovs.14-
15020PMID: 25249609 
49. DeBarmore B, Ashar F, Arking D, Kalyani R, Guallar E, 
Zhang Y, et al. Abstract P049: Mitochondrial DNA 
Copy Number and Diabetes in the ARIC Study. 
American Heart Association; 2017. 
50. Fowler MJ. Microvascular and Macrovascular 
Complications of Diabetes. Clin Diabetes. 
2008;26(2):77-82. DOI: 10.2337/diaclin.26.2.77 
51. Melendez-Ramirez LY, Richards RJ, Cefalu WT. 
Complications of type 1 diabetes. Endocrinol Metab 
Clin North Am. 2010;39(3):625-40. DOI: 
10.1016/j.ecl.2010.05.009PMID: 20723824 
52. Zhang Y, Meng N, Lv Z, Li H, Qu Y. The gene 
polymorphisms of UCP1 but not PPAR gamma and 
TCF7L2 are associated with diabetic retinopathy in 
Chinese type 2 diabetes mellitus cases. Acta 
Ophthalmol. 2015;93(3):e223-9. DOI: 
10.1111/aos.12542PMID: 25274455 
53. Dalgaard LT, Pedersen O. Uncoupling proteins: 
functional characteristics and role in the pathogenesis 
of obesity and Type II diabetes. Diabetologia. 
2001;44(8):946-65. DOI: 
10.1007/s001250100596PMID: 11484071 
54. Cui Y, Xu X, Bi H, Zhu Q, Wu J, Xia X, et al. Expression 
modification of uncoupling proteins and MnSOD in 
retinal endothelial cells and pericytes induced by high 
glucose: the role of reactive oxygen species in 
diabetic retinopathy. Exp Eye Res. 2006;83(4):807-16. 
DOI: 10.1016/j.exer.2006.03.024PMID: 16750827 
55. Brownlee M. Biochemistry and molecular cell biology 
of diabetic complications. Nature. 
2001;414(6865):813-20. DOI: 10.1038/414813aPMID: 
11742414 
56. Parvizi MR, Parviz M, Tavangar SM, Soltani N, 
Kadkhodaee M, Seifi B, et al. Protective effect of 
magnesium on renal function in STZ-induced diabetic 
rats. J Diabetes Metab Disord. 2014;13(1):84. DOI: 
10.1186/s40200-014-0084-3PMID: 25197628 
57. Alizadeh K, Tavangar S-M. Histologic findings in 
idiopathic carpal tunnel syndrome: Report of 209 
cases. Arch Iranian Med. 2002;5(2):100.  
58. Ambrosone CB, Freudenheim JL, Thompson PA, 
Bowman E, Vena JE, Marshall JR, et al. Manganese 
superoxide dismutase (MnSOD) genetic 
polymorphisms, dietary antioxidants, and risk of 
breast cancer. Cancer Res. 1999;59(3):602-6. PMID: 
9973207 
59. Kowluru RA, Kowluru V, Xiong Y, Ho YS. 
Overexpression of mitochondrial superoxide 
dismutase in mice protects the retina from diabetes-
induced oxidative stress. Free Radic Biol Med. 
2006;41(8):1191-6. DOI: 
10.1016/j.freeradbiomed.2006.01.012PMID: 
17015165 
60. Goto Y, Nonaka I, Horai S. A mutation in the 
tRNA(Leu)(UUR) gene associated with the MELAS 
subgroup of mitochondrial encephalomyopathies. 
Nature. 1990;348(6302):651-3. DOI: 
10.1038/348651a0PMID: 2102678 
61. van den Ouweland JM, Lemkes HH, Ruitenbeek W, 
Sandkuijl LA, de Vijlder MF, Struyvenberg PA, et al. 
Mutation in mitochondrial tRNA(Leu)(UUR) gene in a 
large pedigree with maternally transmitted type II 
diabetes mellitus and deafness. Nat Genet. 
1992;1(5):368-71. DOI: 10.1038/ng0892-368PMID: 
1284550 
62. Holmes-Walker DJ, Mitchell P, Boyages SC. Does 
mitochondrial genome mutation in subjects with 
maternally inherited diabetes and deafness decrease 
severity of diabetic retinopathy? Diabet Med. 
1998;15(11):946-52. DOI: 10.1002/(SICI)1096-
9136(1998110)15:11<946::AID-DIA707>3.0.CO;2-
LPMID: 9827849 
 
